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Sex bias in susceptibility to autoimmune diseases is evident but poorly characterized. Yurkovetskiy et al.
(2013) report that host testosterone mediates changes in the microbiome to confer protection to adult
male NOD mice from type 1 diabetes.Autoimmune diseases are disorders
where inappropriate immune responses
are directed toward self-antigens and
result in destruction of self-tissues. It has
long been recognized, both in humans
and in experimental animal models, that
females are affected more than males by
an array of autoimmune diseases (Whita-
cre, 2001). Several explanations for this
observation have traditionally been given,
including different basic immune re-
sponses in females, direct and indirect
modulation of the immune system by
sex hormones, and genetic factors
contributing to the susceptibility of auto-
immune disorders (Pennell et al., 2012).
However, the issue is clearly more com-
plex than these explanations—alone or
in combination—can account for. For
example, it is well known that con-
cordance of autoimmune diseases is low
in homozygotic twin pairs. This low con-
cordance rate argues for the importance
of environmental and epigenetic factors
that are not encoded in the genome but
are critical for the initiation and pro-
gression of these disorders (Mathis and
Benoist, 2012). Research is beginning to
unravel the exact nature of these factors.
A breakthrough in the search for addi-
tional causes of sexual predisposition to
many autoimmune diseases came when
Markle et al. (2013) revealed that sex
differences in mice result in unique gut
microbiomes and that these differences
in the microbiome can drive the sex bias
in autoimmunity in a hormonally depen-
dent pathway. These findings, together
with those of other investigators, strongly
support the idea that the microbiota, as
an environmental and epigenetic factor,
can actively influence host physiology
and impact host disease susceptibility
(Chung et al., 2012; Olszak et al., 2012).208 Immunity 39, August 22, 2013 ª2013 ElsIn this issue of Immunity, Yurkovetskiy
et al. (2013) provide new evidence offering
remarkable insights into the mechanism
underlying what appears to be dual
regulation of sex-biased type 1 diabetes
(T1D) by androgens and the microbiota
(Figure 1). By retrospectively analyzing
literature reports on the occurrence of
T1D in nonobese diabetic (NOD) mice,
the authors show that male-to-female
incidence ratios for T1D vary widely in
NOD mice from facility to facility and
even as a function of time. In contrast,
germ-free male and female NOD mice
always are similarly susceptible to T1D.
The researchers hypothesized that the
compositions of the male and female
microbiotas, which differ over time and
between facilities, influence the sex bias
toward development of T1D in NOD
mice. To directly address this hypothesis,
Yurkovetskiy et al. analyzed the micro-
biota of NOD mice of both sexes
before and after puberty. They found
that female adult mice have microbiomes
similar to those of prepubescent mice
of both sexes; however, the commensal
microbial community in adult male mice
significantly deviates from this shared
initial pool. Strikingly, the authors show
that the microbiome in castrated adult
males clearly shifts away from that of
normal adult males and is closer to the
microbiome of females. The incidence
of T1D in these mice is positively corre-
lated with the ‘‘femaleness’’ of the micro-
biota. Moreover, they demonstrate that
microbiota-mediated sex-biased protec-
tion in males is independent of MyD88.
These results support the hypothesis
that the host androgen level is influential
in determining the composition of the
microbiota, which in turn affects T1D initi-
ation and progression. It will be importantevier Inc.to investigate whether androgen-treated
adult female mice can support a male-
like microbiota and thus be protected
from T1D.
Next, Yurkovetskiy et al. sought to
determine what microbes are uniquely
present in the microbiomes of male and
female NOD mice and which of these
microbes are relevant to sex bias in T1D.
In four independent experiments, the
authors found no universal unique ‘‘male
microbiome’’; however, they did find that
four distinct combinations of microbial
groupings (with an interesting lack of
overlap at the individual family level in
the four experiments) were enhanced by
androgen based upon the input microbial
community. It would have been informa-
tive had similar sex-biased T1D incidence
been verified in these four groups of mice.
By using gnotobiotic techniques, the in-
vestigators found that only certain micro-
bial species enriched in adult males
confer protection from T1D and mediate
the sex bias in gnotobiotic NOD mice.
The two verified species are quite distinct
phylogenetically: one species consists
of the segmented filamentous bacteria
(SFB) and belongs to the Firmicutes,
whereas the other is an Escherichia coli
or Shigella–like (SECS) strain belonging
to the Proteobacteria. These results,
along with the fact that no universal
microbial groups were identified, suggest
that a core set of microbial properties,
functions, or genes, working in concert
with testosterone, is essential for testos-
terone-conferred protection against T1D.
It will be important to analyze the
genome-encoded metabolic pathways
of the four different sets of microbes en-
riched in adult males. It is possible that,
despite taxon diversity, these sets share
a conserved metabolic signature that is
Figure 1. Testosterone and Testosterone-Specific Microbes Lead to Sex-Biased Protection
in T1D
The incidence of T1D is significantly higher in female compared to male NODmice. In the adult NODmale
mouse, a high testosterone level enriches the microbiota for specific organisms such as segmented fila-
mentous bacteria (SFB) and Escherichia coli or Shigella–like (SECS) strains. These microbes also upregu-
late host testosterone. A minimum level of testosterone and specific male-enriched microbes working
together upregulate M2 macrophage and IFN-g producing T cells in pancreatic lymph nodes. Microarray
data show that both the IFN-g and IL-1b pathways are also stimulated. Yurkovetskiy et al. propose that
these pathways lead to a sex-biased protection of T1D.
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(Human Microbiome Project Consortium,
2012). Furthermore, the genomes of SFB
and SECS can be scrutinized by means
of microarrays and RNA sequencing as
alternative approaches to gaining insight
into the ‘‘teaming up’’ of microbial func-
tions with testosterone.
Yurkovetskiy et al. asked whether the
‘‘male microbiomes’’ can impact host
testosterone levels. They found that colo-
nization with protective microbiomes—
e.g., SPF microbiota, SFB, and SECS—
is positively correlated with high blood
testosterone levels in male mice. How-
ever, beyond a concentration of 2 ng/ml,
more testosterone does not confer extra
benefit. Intriguingly, a high testosterone
level alone does not predict protection; a
defined ‘‘complete’’ flora, designated the
altered Schaedler flora, does not protect
NOD males from T1D despite mainte-
nance of the host’s blood testosterone
concentration at 5 ng/ml. Further
complicating the issue is the observation
that SPF males have lower testosterone
levels than germ-free males. These
results suggest that, in addition to testos-
terone and certain microbes, other
unidentified factors are involved in influ-
encing sex-biased protection.Describing the results of studies
designed to reveal how testosterone and
microbes protect against T1D, the
authors report that certain host signaling
networks, including the interferon-g
(IFN-g) and interleukin-1b (IL-1b) path-
ways, are specifically and differentially
expressed in the pancreatic lymph nodes
(PLNs) of male mice due to the presence
of microbiota. They found that M2 macro-
phages are more abundant in SPF males
and are critical for the observed gene-
expression signatures in these mice. In
addition, there was a higher percentage
of IFN-g-producing T cells in PLNs of
male mice than in PLNs of female and
castrated male mice. Finally, they
confirmed that, after exposure to SECS,
peritoneal macrophages from adult males
are more efficient in eliciting IFN-g from
insulin-specific CD8+ T cells than are
those from females. These experiments
call for elucidation of mechanisms that
could paradoxically link the M2 macro-
phage and the activation of the IFN-g
pathway in T cells. Another appealing
study would be to determine whether
these same genes are upregulated when
adult males are colonized with each of
the four different microbial combinations
identified. It will also be interesting toImmunity 39investigate whether similar M2 macro-
phage activity and IFN-g production are
involved in protection in other T1D dis-
ease models.
A direct implication of this study is that
probiotic administration or fecal trans-
plantation is a theoretically possible
approach to protection against T1D.
However, such an approach is impractical
because of the inability to prospectively
identify people at risk. It is also unclear
how long the conferred protection would
last because the microbiota is highly
host-specific (Chung et al., 2012) and
androgen is probably required continually
to retain the transplanted male signatures
of the microbiome. Another more funda-
mental approach is to identify the detailed
pathways and molecules from both host
and microbes that mediate protection
and to translate this knowledge into the
designing of new therapeutics. This
approach is very promising but also chal-
lenging. So far, just a handful of microbes,
including Bacteroides fragilis and SFB,
have known molecular interactions with
the host immune system (Chow et al.,
2010). Nonetheless, this study and the
earlier report by Markle et al. (2013) have
established a new direction for treating
autoimmune diseases.
Intestinal microbes are immersed in
a complex host chemical and biological
environment that not only provides
a nutrient-rich niche but also imposes
tremendous selection pressure on the
microbiota (An et al., 2011). How specific
host factors and the microbiota shape
each other and together impact health
and disease is a question that has
attracted increasing interest in the past
decade. The work by Yurkovetskiy et al.
is an important contribution to elucidation
of the role of interplay between sex
hormones and the microbiota in disease
susceptibility. Only a few other types of
hormones—for example, those involved
in pregnancy and stress-response—
have been suggested as having a
possible role in regulation of the
microbiome. Indeed, as critical mes-
sengers delivering signals from one cell
to another, it is not surprising that hor-
mones might mediate direct conver-
sations between host cells and symbiotic
microbes, which have coevolved for eons.
Insights from these conversations will
undoubtedly enhance the quality of health
care., August 22, 2013 ª2013 Elsevier Inc. 209
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